Literature DB >> 6134470

Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy.

P K Ganguly, G N Pierce, K S Dhalla, N S Dhalla.   

Abstract

The effects of insulin and thyroid hormone treatments on cardiac sarcoplasmic reticular function were investigated in chronic streptozotocin-induced diabetes in rats. ATP-dependent Ca2+ transport and Ca2+-stimulated ATPase activities were depressed significantly in microsomal samples from diabetic rats in comparison with control (P less than 0.05). This defect was seen at various times of incubation (1-20 min) and different concentrations of free Ca2+ (10(-7) to 10(-5) M Ca2+) and was accompanied by changes in the protein composition and phospholipid contents of the microsomal fraction. The defect in calcium transport in microsomal vesicles was not evident until 28 days after streptozotocin (65 mg/kg iv) injection, whereas increases in plasma glucose levels due to insulin-deficiency occurred within 3 days. All changes in function and composition of the sarcoplasmic reticulum were reversed by insulin administration to the diabetic rats. Although the plasma level of thyroid hormone was decreased in the diabetic rat, thyroid hormone treatment did not restore microsomal calcium transport in the diabetic animals. The results of this study provide some evidence that the depression in cardiac sarcoplasmic reticular calcium accumulation during diabetes is a consequence of insulin deficiency and associated chronic metabolic changes but the hypothyroid condition that accompanies experimental diabetes does not appear to play any role in this defect.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134470     DOI: 10.1152/ajpendo.1983.244.6.E528

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  91 in total

1.  Fura-2 fluorescent technique for the assessment of Ca2+ homeostasis in cardiomyocytes.

Authors:  Y J Xu; Q Shao; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

2.  Effects of amino acid supplementation on myocardial cell damage and cardiac function in diabetes.

Authors:  Paramjit S Tappia; James Thliveris; Yan-Jan Xu; Nina Aroutiounova; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2011

3.  Age-related regulation of excitation-contraction coupling in rat heart.

Authors:  Hilmi B Kandilci; Erkan Tuncay; Esma N Zeydanli; Nazli N Sozmen; Belma Turan
Journal:  J Physiol Biochem       Date:  2011-02-02       Impact factor: 4.158

4.  Fatty acid synthase modulates homeostatic responses to myocardial stress.

Authors:  Babak Razani; Haixia Zhang; P Christian Schulze; Joel D Schilling; John Verbsky; Irfan J Lodhi; Veli K Topkara; Chu Feng; Trey Coleman; Attila Kovacs; Daniel P Kelly; Jeffrey E Saffitz; Gerald W Dorn; Colin G Nichols; Clay F Semenkovich
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

5.  Abnormal myocardial perfusion and contractile recruitment during exercise in type 1 diabetic patients.

Authors:  Roldano Scognamiglio; Christian Negut; Saula Vigili de Kreuizenberg; Monica Palisi; Antonio Tiengo; Angelo Avogaro
Journal:  Clin Cardiol       Date:  2005-02       Impact factor: 2.882

6.  Decrease in cardiac phosphatidylglycerol in streptozotocin-induced diabetic rats does not affect cardiolipin biosynthesis: evidence for distinct pools of phosphatidylglycerol in the heart.

Authors:  G M Hatch; S G Cao; A Angel
Journal:  Biochem J       Date:  1995-03-15       Impact factor: 3.857

7.  Decreased sensitivity of contraction to changes of intracellular pH in papillary muscle from diabetic rat hearts.

Authors:  D Lagadic-Gossmann; D Feuvray
Journal:  J Physiol       Date:  1990-03       Impact factor: 5.182

8.  Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats.

Authors:  L Golfman; I M Dixon; N Takeda; A Lukas; K Dakshinamurti; N S Dhalla
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 9.  Role of microangiopathy in diabetic cardiomyopathy.

Authors:  Adriana Adameova; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2014-01       Impact factor: 4.214

10.  Diabetes-induced changes in cardiac beta-adrenoceptor responsiveness: effects of aldose reductase inhibition with ponalrestat.

Authors:  C E Austin; R Chess-Williams
Journal:  Br J Pharmacol       Date:  1991-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.